SCHEMBL21467077

SCHEMBL21467077

COc1ccc2oc(Cn3cnc4c(N)ncnc43)c(C3=CCCC=C3)c(=O)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NSD3 Q9BZ95 5/20 0.42
▸ PIK3CD O00329 2/20 0.39
▸ NSD2 O96028 8/20 0.37
▸ PI4KA P42356 4/20 0.37
▸ PI4K2B Q8TCG2 4/20 0.37
▸ PI4K2A Q9BTU6 4/20 0.37
▸ PI4KB Q9UBF8 4/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ADORA2A P29274 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30670853 0.83 PIK3CD (0.47) NSD3PIK3CDPI4KAPI4K2BPI4K2A
SCHEMBL9009 0.83 PIK3CD (0.47) NSD3PIK3CDPI4KAPI4K2BPI4K2A
SCHEMBL130916 0.72 ADORA2A (0.48) PIK3CDPI4KAPI4K2BPI4K2API4KB
SCHEMBL8577 0.72 ADORA2A (0.53) PIK3CDPI4KAPI4K2BPI4K2API4KB
SCHEMBL29651680 0.72 ADORA2A (0.53) PIK3CDPI4KAPI4K2BPI4K2API4KB
SCHEMBL8903 0.71 ADORA2A (0.49) NSD3PIK3CDNSD2PI4KAPI4K2B
SCHEMBL30013159 0.71 ADORA2A (0.49) NSD3PIK3CDNSD2PI4KAPI4K2B
SCHEMBL19113768 0.71 PIK3CD (0.55) PIK3CDPI4KAPI4K2BPI4K2API4KB
SCHEMBL13729010 0.70 NSD2 (0.43) NSD3PIK3CDNSD2PI4KAPI4K2B
SCHEMBL7930 0.70 ADORA2A (0.48) NSD3PIK3CDNSD2PI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases PIK3CB, PIK3CD, PDPK1 NSD3 2598/4885PIK3CD 2/4885NSD2 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback